/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

R

Rami S. Komrokji

Moffitt Cancer Center(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

1.5K

Papers

18.6K

Citations

68

h-index

322

i10-index

Rami S. Komrokji is an academic researcher from Moffitt Cancer Center. The author has contributed to research in topics: Acute Myeloid Leukemia Research & Myeloproliferative Neoplasms: Diagnosis and Treatment & Chronic Myeloid Leukemia Treatments. The author has an h-index of 68, co-authored 1268 publications.

ORCID: 0000-0002-1876-5269

Research Topics

Acute Myeloid Leukemia Research Myeloproliferative Neoplasms: Diagnosis and Treatment Chronic Myeloid Leukemia Treatments Chronic Lymphocytic Leukemia Research Hemoglobinopathies and Related Disorders

Papers by this author

works

Clonal haemopoiesis and therapy-related myeloid malignancies in elderly patients: a proof-of-concept, case-control study

2016 · The Lancet Oncology · 307 citations

https://doi.org/10.1016/s1470-2045(16)30627-1

Nancy Gillis Markus Ball Qing Zhang Zhenjun Ma

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

2021 · Leukemia · 172 citations

https://doi.org/10.1038/s41375-021-01328-9

David P. Steensma Martin Wermke Virginia M. Klimek Peter L. Greenberg

Efficacy and safety of luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): interim analysis of a phase 3, open-label, randomised controlled trial

2023 · The Lancet · 154 citations

https://doi.org/10.1016/s0140-6736(23)00874-7

Uwe Platzbecker Matteo Giovanni Della Porta Valeria Santini Amer M. Zeidan

TIM-3 pathway dysregulation and targeting in cancer

2020 · Expert Review of Anticancer Therapy · 87 citations

https://doi.org/10.1080/14737140.2021.1865814

Amer M. Zeidan Rami S. Komrokji Andrew M. Brunner

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

2020 · The Lancet Haematology · 86 citations

https://doi.org/10.1016/s2352-3026(20)30205-2

Amer M. Zeidan Prajwal Boddu Mrinal M. Patnaik Jan Philipp Bewersdorf

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

2020 · Leukemia · 73 citations

https://doi.org/10.1038/s41375-020-0917-7

Andrea Kuendgen Meritxell Nomdedéu Heinz Tuechler Guillermo Garcia‐Manero

Research topics

topics

Acute Myeloid Leukemia Research

Myeloproliferative Neoplasms: Diagnosis and Treatment

Chronic Myeloid Leukemia Treatments

Chronic Lymphocytic Leukemia Research

Hemoglobinopathies and Related Disorders

Chat about Author

Papers

Chat

Click to start Chat